Promoter Jay Arvind Bhanushali bought 1,424 shares of Aspira Pathlab & Diagnostics Limited in the open market, raising his stake from 7.27% to 7.28%. This is the sixth open-market purchase by the promoter group in 30 days.
Aspira Pathlab & Diagnostics Limited is a Mumbai-based pathology and diagnostic healthcare services company established in 1973. It operates multiple diagnostic centers offering pathology tests, sonography, X-ray, 2D echocardiography, and specialized health screening packages. The company holds NABL accreditation and positions itself with over 50 years of experience in diagnostic services. It is listed on the BSE (code 540788) and serves patients through in-center and home-based blood collection services across India.
